All In Biotech

Free tool

FAERS Monitor: Vancomycin Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209481 or its brand name (Vancomycin Hydrochloride, Vancomycin Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

7,339

Serious

6,612

90% of reports

Hospitalization

3,189

Death reported

1,453

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective850
  • acute kidney injury498
  • off label use460
  • pyrexia433
  • rash309
  • drug reaction with eosinophilia and systemic symptoms300
  • drug hypersensitivity289
  • condition aggravated267
  • pneumonia262
  • diarrhoea255
  • sepsis252
  • hypotension225
  • pruritus203
  • dyspnoea202
  • renal failure202

Reports by year received

View as table
YearReports
200461
200551
200682
2007150
2008270
200999
201091
2011106
2012152
2013196
2014154
2015265
2016160
2017180
2018265
2019387
2020419
2021628
2022916
2023918
2024771
2025653
2026364

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,820 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug reaction with eosinophilia and systemic symptomsSignal30033.830.29,416
acute kidney injurySignal4989.48.63,722
sepsisSignal2526.55.71,168
renal failureSignal2024.43.8523
drug hypersensitivitySignal2894.33.8730
pyrexiaSignal4333.63.3819
hypotensionSignal2253.22.8344
condition aggravatedSignal2672.52.2246
pneumoniaSignal2622.32.1198
rashSignal3092.01.8164
drug ineffective8501.81.7352
pruritus2031.51.336
off label use4601.51.481
diarrhoea2551.11.04
dyspnoea2021.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.